DFP00173
CAS No. 672286-03-2
DFP00173( —— )
Catalog No. M26152 CAS No. 672286-03-2
DFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 258 | Get Quote |
|
| 10MG | 402 | Get Quote |
|
| 25MG | 664 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | 1242 | Get Quote |
|
| 500MG | 2511 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDFP00173
-
NoteResearch use only, not for human use.
-
Brief DescriptionDFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM.
-
DescriptionDFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM. Compared with the homologous AQP subtypes AQP7 and AQP9, DFP00173 is selective for AQP3.(In Vitro):DFP00173 inhibits the glycerol permeability of human red blood cells with IC50 of ~0.2 μM.
-
In VitroDFP00173 inhibits the glycerol permeability of human erythrocytes with an IC50 of ~0.2 μM.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number672286-03-2
-
Formula Weight332.16
-
Molecular FormulaC11H7Cl2N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (301.06 mM)
-
SMILES[O-][N+](=O)c1cc(NC(=O)Nc2c(Cl)cccc2Cl)cs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.S Moein Moghimi, et al. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021 Mar 3;29(3):898-900.
molnova catalog
related products
-
ES9-17
ES9-17, an analog of ES9 (endosidin9), is an inhibitor of clathrin-mediated endocytosis (CME). ES9-17 inhibits the uptake of FM4-64 and transferrin. ES9-17 inhibits root growth of Arabidopsis seedings.
-
Lonidamine
Lonidamine is an orally administered small molecule hexokinase inactivator.
-
MIF098
MIF098, a macrophage migration inhibitory factor (MIF) antagonist, inhibits pulmonary hypertension associated with SLE and the proliferation and migration of pulmonary arterial smooth muscle cells (PASMC).
Cart
sales@molnova.com